XIMLUCI
LIVE

Serial Number

79437087

Owner

STADA Arzneimittel AG

Attorney

Charles T. J. Weigell

Filing Date

Oct 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

XIMLUCI Trademark

Serial Number: 79437087

XIMLUCI is a trademark filed by STADA Arzneimittel AG on October 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

STADA Arzneimittel AG

Stadastraße 2-18
Bad Vilbel 61118 , DE

Entity Type: 03

Trademark Details

Filing Date

October 14, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Surgical instruments and apparatus; medical apparatus, namely, applicators in the nature of droppers sold empty and syringes for administering medications into the human eye; medical apparatus, namely, instruments for introducing pharmaceutical preparations into the human body; medical apparatus, namely, diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders

Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans; diagnostic preparations for medical purposes; medical and surgical dressings

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 28, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 28, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 28, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 26, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 26, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 2, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 1, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 26, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2025 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 13, 2025 SDRC